Jama Internal Medicine

雜志介紹

Jama Internal Medicine雜志介紹

《Jama Internal Medicine》是一本以English為主的未開放獲取國際優秀期刊，中文名稱賈瑪內科，本刊主要出版、報道醫學-MEDICINE, GENERAL & INTERNAL領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為22.5，最新CiteScore 指數為43.5。

本刊近期中國學者發表的論文主要有：

• Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis C

  Author: Ogawa, Eiichi; Chien, Nicholas; Kam, Leslie; Yeo, Yee Hui; Ji, Fanpu; Huang, Daniel Q.; Cheung, Ramsey; Nguyen, Mindie H.

• Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials A Systematic Review and Meta-analysis

  Author: Xiao, Hong; Vaidya, Riha; Liu, Fang; Chang, Ximing; Xia, Xiaoqian; Unger, Joseph M.

• Healthy Eating Patterns and Risk of Total and Cause-Specific Mortality

  Author: Shan, Zhilei; Wang, Fenglei; Li, Yanping; Baden, Megu Y. Y.; Bhupathiraju, Shilpa N. N.; Wang, Dong D. D.; Sun, Qi; Rexrode, Kathryn M.; Rimm, Eric B. B.; Qi, Lu; Tabung, Fred K. K.; Giovannucci, Edward L. L.; Willett, Walter C. C.; Manson, JoAnn E. E.; Qi, Qibin; Hu, Frank B. B.

• Adherence to Healthy Lifestyle Prior to Infection and Risk of Post-COVID-19 Condition

  Author: Wang, Siwen; Li, Yanping; Yue, Yiyang; Yuan, Changzheng; Kang, Jae Hee; Chavarro, Jorge E. E.; Bhupathiraju, Shilpa N. N.; Roberts, Andrea L. L.

英文介紹

Jama Internal Medicine雜志英文介紹

JAMA Internal Medicine is an international peer-reviewed journal providing innovative and clinically relevant research for practitioners in general internal medicine and internal medicine subspecialties. We strive to publish articles that are stimulating to read, educate and inform readers with the most up-to-date research, and lead to positive change in our health care systems and the way we deliver patient care. JAMA Internal Medicine is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. Articles published in JAMA Internal Medicine have led to actions by the FDA and congressional hearings on matters of patient safety that have put into place better measures to protect the public.